THE SWISS HELVETIA FUND, INC.
 
Schedule of Investments by Industry (Unaudited)
 
September 30, 2024
 
                 
                 
             
Percent
 
No. of
           
of Net
 
Shares
 
Security
 
Value
   
Assets
 
Common Stock — 93.38%
           
Advertising — 0.48%
           
 
8,000
 
DKSH Holding AG
   
637,307
     
0.48
%
     
An international marketing and services group. The company offers a comprehensive package of services that includes organizing and running the entire value chain for any product.
               
     
(Cost $515,995)
               
           
637,307
     
0.48
%
                       
Banks — 3.22%
               
 
1,500
 
St Galler Kantonalbank AG
   
737,064
     
0.55
%
     
St. Galler Kantonalbank AG is a Swiss Regional bank. The Bank offers retail and commercial banking as well as private and institutional banking. SGKB also provides asset management and financial planing services. The Bank offers its services in the Canton of St. Gall through a network of branches.
               
     
(Cost $753,505)
               
 
116,000
 
UBS Group AG
   
3,583,617
     
2.67
%
     
Provides retail banking, corporate and institutional banking, wealth management, asset management and investment banking.
               
     
(Cost $1,582,000)
               
           
4,320,681
     
3.22
%
                       
Biotechnology — 2.33%
               
 
10,801
 
Bachem Holding AG
   
911,660
     
0.68
%
     
Specializes in the development and manufacture of peptides and oligonucleotides. The company provides products for research, clinical development and commercial application to pharamceutical and biotechnology companies.
               
     
(Cost $827,767)
               
 
3,500
 
Lonza Group AG
   
2,218,126
     
1.65
%
     
Produces organic fine chemicals, biocides, active ingredients, and biotechnology products.
               
     
(Cost $1,871,039)
               
           
3,129,786
     
2.33
%
                       
Building Materials — 2.01%
               
 
8,100
 
Sika AG
   
2,689,598
     
2.01
%
     
Manufactures construction materials, producing concrete and mixtures, mortar, sealants and adhesives, tooling resins, anti-static industrial flooring, and acoustic materials. The company serves customers worldwide.
               
     
(Cost $1,482,802)
               
           
2,689,598
     
2.01
%
                       
Chemicals — 1.64%
               
 
400
 
Givaudan SA
   
2,200,225
     
1.64
%
     
Manufactures and markets fragrances and flavors from natural and synthetic ingredients. The Company sells its products to manufactures of perfumes, beverages, prepared foods, and consumer goods.
               
     
(Cost $1,207,567)
               
           
2,200,225
     
1.64
%
                       
Computers — 0.80%
               
 
12,000
 
Logitech International SA
   
1,074,886
     
0.80
%
     
Engages in the development and marketing of hardware and software products that enable or enhance digital navigation, music and video entertainment, gaming, social networking and audio and video communication.
               
     
(Cost $162,698)
               
           
1,074,886
     
0.80
%
                       
Diversified Financial Services — 3.23%
               
 
22,400
 
Julius Baer Group Ltd.
   
1,351,621
     
1.01
%
     
Provides private banking services. The company advises on wealth management, financial planning and investments; offers mortgage and other lending, foreign exchange, securities trading, custody and execution services.
               
     
(Cost $1,027,660)
               
 
4,600
 
Swissquote Group Holding SA
   
1,659,937
     
1.24
%
     
Through its subsidiaries, offers online financial services. The company operates an online trading system which offers customers real-time securities quotes on the Swiss Stock Exchange.
               
     
(Cost $444,009)
               
 
8,200
 
VZ Holding AG
   
1,316,200
     
0.98
%
     
Provides independent financial advice to private individuals and companies. The company consults on investment, tax and inheritance planning and provides advice regarding insurance products and coverage.
               
     
(Cost $267,551)
               
           
4,327,758
     
3.23
%
                       
Electric — 1.36%
               
 
10,000
 
BKW AG
   
1,818,505
     
1.36
%
     
Provides energy supply services. The company focuses on the production, transportation, trading and sale of energy. In addition to energy supply, the company also develops, implements and operates energy solutions for its clients.
               
     
(Cost $623,498)
               
           
1,818,505
     
1.36
%
                       
Electronic Components & Equipment — 4.57%
               
 
58,300
 
ABB Ltd.
   
3,385,830
     
2.52
%
     
Provides power and automation technologies. The company operates under segments that include power products, power systems, automation products, process automation, and robotics.
               
     
(Cost $1,894,633)
               
 
1,900
 
Comet Holding AG
   
751,171
     
0.56
%
     
Develops, produces, and distributes components and systems for x-ray tubes, vacuum condensers, and radio frequency, as well as other medical products.
               
     
(Cost $381,063)
               
 
87,254
 
R&S Group Holding AG
   
1,996,328
     
1.49
%
     
Manufactures small and medium power and distribution transformers and other components in the utility, infrastructure, and industrial sectors.
               
     
(Cost $992,256)
               
           
6,133,329
     
4.57
%
                       
Food — 15.11%
               
 
1,142,000
 
Aryzta AG 2
   
2,194,514
     
1.64
%
     
Produces and retails specialty bakery products. The Company produces French breads, pastries, continental breads, confections, artisan breads, homestyle lunches, viennoiserie, patisserie, cookies, pizza, appetizers, and sweet baked goods.
               
     
(Cost $1,165,555)
               
 
840
 
Barry Callebaut AG
   
1,559,409
     
1.16
%
     
Manufactures cocoa and chocolate products. The Company markets to industrial food manufacturers, chocolatiers, pastry chefs, bakers, and retailers globally.
               
     
(Cost $1,554,846)
               
 
164,000
 
Nestle SA
   
16,517,622
     
12.31
%
     
One of the world's largest food and beverage processing companies.
               
     
(Cost $9,388,046)
               
           
20,271,545
     
15.11
%
                       
Health Care — 2.59%
               
 
64,300
 
Sandoz Group AG
   
2,688,473
     
2.01
%
     
Manufactures and distributes generic and biosimilar medicines for the treatment of patients with diseases such as cancer, diabetes, and arthritis.
               
     
(Cost $1,402,776)
               
 
1,600
 
Ypsomed Holding AG
   
781,459
     
0.58
%
     
Develops and manufactures custom-made injection systems for pharmaceutical and bio-technology companies.
               
     
(Cost $458,298)
               
           
3,469,932
     
2.59
%
                       
Healthcare-Products — 6.97%
               
 
24,000
 
Alcon, Inc.
   
2,399,004
     
1.79
%
     
Manufactures eye care products. The company produces and markets vitreoretinal and cataract surgery, contact lenses, and refractive technology products.
               
     
(Cost $1,541,567)
               
 
6,600
 
Medacta Group SA
   
978,010
     
0.73
%
     
Produces and distributes medical devices. The company develops, manufactures, and distributes orthopedic and neurosurgical medical devices.
               
     
(Cost $720,575)
               
 
6,848
 
SKAN Group AG
   
647,010
     
0.48
%
     
Provides health care supplies. The Company offers isolators, cleanroom devices, and decontamination processes for the aseptic production of the biopharmaceutical products.
               
     
(Cost $530,142)
               
 
1,900
 
Sonova Holding AG
   
684,275
     
0.51
%
     
Designs and produces wireless analog and digital in-the-ear and behind-the-ear hearing aids and miniaturized voice communications systems.
               
     
(Cost $289,598)
               
 
221,085
 
Spineart SA 1,2
   
1,454,593
     
1.08
%
     
Designs and markets an innovative full range of spine products, including fusion and motion preservation devices, focusing on easy to implant high-end products to simplify the surgical act.
               
     
(Cost $1,554,486)
               
 
8,000
 
Straumann Holding AG
   
1,311,126
     
0.98
%
     
Straumann Holding AG develops, produces and sells dental implants. The company manufactures metal devices implantable in the jaw, in place of missing teeth, to which prostetic teeth are attached. Straumann has subsidiaries throughout Europe and North America. The Company sells its products worldwide.
               
     
(Cost $1,058,271)
               
 
5,700
 
Tecan Group AG
   
1,881,192
     
1.40
%
     
Manufactures and distributes laboratory automation components and systems. The products are mainly used by research and diagnostic laboratories.
               
     
(Cost $785,966)
               
           
9,355,210
     
6.97
%
                       
Healthcare - Services — 0.74%
               
 
11,300
 
Galenica AG
   
997,315
     
0.74
%
     
Retails pharmaceutical products, and services customers in Switzerland. The Company offers health, beauty, and related products and services.
               
     
(Cost $902,693)
               
           
997,315
     
0.74
%
                       
Industrials — 1.88%
               
 
1,252
 
Belimo Holding AG
   
895,717
     
0.67
%
     
Manufactures heating, ventilation and air conditioning equipment.
               
     
(Cost $144,479)
               
 
4,976
 
Georg Fischer AG
   
376,643
     
0.28
%
     
Greorg Fischer AG is a global supplier in the safe transportation of liquids and gases, in the production of lightweight casting components and high-precision manufacturing technologies. Headquartered in Switzerland, it was founded in 1802. The company is located in over 30 countries. Georg fischer comprises of three divisions: GF Piping Systems, GF Casting Solutions, and GF Machining.
               
     
(Cost $342,850)
               
 
230,000
 
OC Oerlikon Corp. AG
   
1,248,225
     
0.93
%
     
Manufactures industrial equipment. The Company produces protective coatings for precision tools and components, equipment for textile production, and propulsion technology drive systems.
               
     
(Cost $2,526,045)
               
           
2,520,585
     
1.88
%
                       
Information Technology — 0.43%
               
 
1,800
 
ALSO Holding AG
   
578,270
     
0.43
%
     
Wholesales information technology and consumer electonics products. The Company's products include computer hardware and software.
               
     
(Cost $512,678)
               
           
578,270
     
0.43
%
                       
Insurance — 7.18%
               
 
4,900
 
Baloise Holding AG
   
1,002,015
     
0.75
%
     
Offers group and individual life, health, accident, liability property, and transportation insurance to customers in Europe. The Company also offers private banking and asset management services.
               
     
(Cost $720,253)
               
 
6,600
 
Helvetia Holding AG
   
1,142,315
     
0.85
%
     
Provides a broad range of life, casualty, liability, accident and transportation insurance in Switzerland and in other European countries. The Company insures individuals, property such as vehicles and buildings, and consumer goods and personal belongings
               
     
(Cost $570,981)
               
 
2,450
 
Swiss Life Holding AG
   
2,050,501
     
1.53
%
     
Provides life insurance and institutional investment management.
               
     
(Cost $560,146)
               
 
9,000
 
Zurich Insurance Group AG
   
5,439,156
     
4.05
%
     
Provides insurance-based financial services. The company offers general and life insurance products and services for individuals, small businesses, commercial enterprises, mid-sized and large corporations, and multinational companies.
               
     
(Cost $2,889,300)
               
           
9,633,987
     
7.18
%
                       
Machinery-Diversified — 0.85%
               
 
22,000
 
Accelleron Industries AG
   
1,143,358
     
0.85
%
     
Develops, produces, and services turbochargers and large turbocharging components. The Company offers turbocharging technologies and optimization solutions for engines thereby reducing the environmental impact with less fuel emissions.
               
     
(Cost $386,769)
               
           
1,143,358
     
0.85
%
                       
Metal Fabricate/Hardware — 1.34%
               
 
11,500
 
SFS Group AG
   
1,799,538
     
1.34
%
     
Provides automotive products, building and electronic components, flat roofing and solar fastening systems. The company operates production facilities in Asia, Europe and North America.
               
     
(Cost $778,227)
               
           
1,799,538
     
1.34
%
                       
Packaging & Containers — 1.62%
               
 
97,000
 
SIG Combibloc Group AG
   
2,168,716
     
1.62
%
     
The company, through its subsidiaries, manufactures and produces bottling machines and systems for the food and beverage industries. The company serves customers worldwide.
               
     
(Cost $1,384,254)
               
           
2,168,716
     
1.62
%
                       
Pharmaceuticals — 23.65%
               
 
23,200
 
Galderma Group AG 2
   
2,161,721
     
1.61
%
     
Delivers scirnce-based portfolio of brands and services that span the full spectrum of self-care dermatology market through injectable aesteticss, dermatological skincare, and therapeutic dermatology. The company serves customerss worldwide..
               
     
(Cost $1,367,362)
               
 
140,000
 
Novartis AG
   
16,123,525
     
12.02
%
     
One of the leading manufacturers of branded and generic pharmaceutical products.
               
     
(Cost $6,851,499)
               
 
41,880
 
Roche Holding AG
   
13,434,566
     
10.02
%
     
Develops and manufactures pharmaceutical and diagnostic products. Produces prescription drugs to treat cardiovascular, infectious and autoimmune diseases and for other areas including dermatology and oncology.
               
     
(Cost $7,268,153)
               
           
31,719,812
     
23.65
%
                       
Private Equity — 2.64%
               
 
2,350
 
Partners Group Holding AG
   
3,538,024
     
2.64
%
     
A global private markets investment management firm with investment programs under management in private equity, private real estate, private infrastructure and private debt. The firm manages a broad range of customized portfolios for an international clientele of institutional investors. Partners Group is headquartered in Zug, Switzerland.
               
     
(Cost $1,796,137)
               
           
3,538,024
     
2.64
%
                       
Retail — 6.41%
               
 
43,400
 
Cie Financiere Richemont SA
   
6,883,907
     
5.13
%
     
Manufactures and retails luxury goods. Produces jewelry, watches, leather goods, writing instruments and men’s and women’s wear.
               
     
(Cost $3,343,993)
               
 
40,000
 
Swatch Group AG - Registered Shares
   
1,718,926
     
1.28
%
     
Manufactures finished watches, movements and components. Produces components necessary to its various watch brand companies. The company also operates retail boutiques.
               
     
(Cost $2,466,618)
               
           
8,602,833
     
6.41
%
                       
Semiconductors — 0.82%
               
 
78,605
 
ams-OSRAM AG 2
   
1,100,501
     
0.82
%
     
Designs and manufactures advanced sensor solutions. The company also delivers a broad range of technology solutions for consumer electronics and communication device manufactures.
               
     
(Cost $2,267,258)
               
           
1,100,501
     
0.82
%
                       
Transportation — 1.51%
               
 
7,400
 
Kuehne + Nagel International AG
   
2,024,681
     
1.51
%
     
Transports freight worldwide. The company operates sea, land, and rail freight transportation businesses and warehousing and distribution facilities.
               
     
(Cost $2,030,349)
               
           
2,024,681
     
1.51
%
                       
     
Total Common Stock
               
     
(Cost $73,594,213)
   
125,256,382
     
93.38
%
                     
                     
Limited Partnership — 0.42%
               
Biotechnology — 0.42%
               
 
3,294,705
 
Aravis Biotech II, Limited Partnership 1,2
   
566,218
     
0.42
%
     
Makes early stage venture investments in the biotechnology & pharmaceuticals industry.
               
     
(Cost $213,885)
               
           
566,218
     
0.42
%
                       
     
Total Limited Partnership
               
     
(Cost $213,885)
   
566,218
     
0.42
%
                     
Short-Term Investment — 0.27%
               
 
364,226
 
U.S. Bank Money Market Deposit Account, 1.55%
   
364,226
     
0.27
%
                       
     
(Cost $364,226)
               
           
364,226
     
0.27
%
                       
     
Total Short-Term Investment
               
     
(Cost $364,226)
   
364,226
     
0.27
%
                       
                     
     
Total Investments 5
               
     
(Cost $74,172,324)
   
126,186,826
     
94.07
%
                       
     
Other Assets Less Liabilities 5
   
7,950,855
     
5.93
%
     
Net Assets
 
$
134,137,681
     
100.00
%
   
                       
Net Asset Value Per Share:
               
     
($134,137,681 ÷ 12,990,705
shares outstanding,
$0.001 par value: 50 million
shares authorized)
         
$
10.33
 
                       
See Notes to Schedule of Investments
 

THE SWISS HELVETIA FUND, INC.
 
Schedule of Investments by Industry
                           
September 30, 2024
 
(continued)
                                               
                                                 
1 Non-income producing security.
                                           
2 Value determined using significant unobservable inputs.
                                     
3 Illiquid. There is not a public market for these securities in the United States or in any foreign jurisdiction, including Switzerland. Securities are priced
 
at Fair Value in accordance with the Fund's valuation policy and procedures. At the end of the period, the aggregate Fair Value of these securities amounted
 
to $1,454,593 or 1.08% of the Fund's net assets. Additional information on these securities is as follows:
                   
                                                 
Security
         
Acquisition Date
               
Cost
 
Aravis Biotech II, Limited Partnership
         
July 31, 2007 – May 29, 2018
               
$
213,885
 
Spineart SA – Common Shares
         
December 22, 2010 - December 20, 2020
                 
1,554,486
 
                                         
$
1,768,371
 
                                                   
4 Affiliated Company. An affiliated company is a company in which the Fund has ownership of at least 5% of the company's outstanding voting
         
securities or an equivalent interest in the company. Details related to affiliated company holdings are as follows:
               
                                                   
                                 
Change in
               
   
Value
   
Gross
   
Gross
   
Corporate
   
Realized
   
Unrealized
   
Interest
   
Value
 
Name of Issuer
 
as of 12/31/23
   
Additions
   
Reductions
   
Actions
   
Gain/(Loss)
   
Gain/(Loss)
   
Income
   
as of 9/30/24
 
Aravis Biotech II, Limited Partnership
 
$
997,278
   
$
-
   
$
-
   
$
-
   
$
-
   
$
(431,060
)
 
$
-
   
$
566,218
 
   
$
997,278
   
$
-
   
$
-
   
$
-
   
$
-
   
$
(431,060
)
 
$
-
   
$
566,218
 
                                                                 
5 All of the Fund's investments and other assets are pledged as collateral in accordance with a credit agreement with U.S. Bank, National Association.
 
                                                                 
See Notes to Schedule of Investments
 
                                                                 

PORTFOLIO HOLDINGS
     
% of Net Assets as of September 30, 2024
     
Pharmaceuticals
   
23.65
%
Food
   
15.11
%
Insurance
   
7.18
%
Healthcare-Products
   
6.97
%
Retail
   
6.41
%
Electronic Components & Equipment
   
4.57
%
Diversified Financial Services
   
3.23
%
Banks
   
3.22
%
Private Equity
   
2.64
%
Health Care
   
2.59
%
Biotechnology
   
2.33
%
Building Materials
   
2.01
%
Industrials
   
1.88
%
Chemicals
   
1.64
%
Packaging & Containers
   
1.62
%
Transportation
   
1.51
%
Electric
   
1.36
%
Metal Fabricate/Hardware
   
1.34
%
Machinery-Diversified
   
0.85
%
Semiconductors
   
0.82
%
Computers
   
0.80
%
Healthcare - Services
   
0.74
%
Advertising
   
0.48
%
Information Technology
   
0.43
%
Biotechnology
   
0.42
%
Short-Term Investment
   
0.27
%
Other Assets Less Liabilities
   
5.93
%
     
100
%
 
       

TOP 10 PORTFOLIO HOLDINGS
     
% of Net Assets as of September 30, 2024
     
Nestle SA
   
12.31
%
Novartis AG
   
12.02
%
Roche Holding AG
   
10.02
%
Cie Financiere Richemont SA
   
5.13
%
ZURICH INSURANCE GROUP AG
   
4.05
%
UBS Group AG
   
2.67
%
Partners Group Holding AG
   
2.64
%
ABB Ltd
   
2.52
%
Sika AG
   
2.01
%
Sandoz Group AG
   
2.01
%
 
       

THE SWISS HELVETIA FUND, INC.

 
Notes to Schedule of Investments (Unaudited)
 
Various inputs are used to determine the value of the Fund’s investments. These inputs are summarized in the three broad levels listed below:

Level 1—unadjusted quoted prices in active markets for identical assets and liabilities
Level 2—other significant observable inputs (including quoted prices of similar securities, interest rates, prepayment speeds, credit risk, etc.)
Level 3—significant unobservable inputs (including the Fund’s own assumptions in determining the fair value of investments)

The inputs or methodology used for valuing securities are not an indication of the risk associated with investing in those securities.

The following is a summary of the inputs used to value the Fund’s investments as of September 30, 2024:

TOPIC 820 TABLE
 
                               
Investments in Securities*
 
Level 1
Quoted Prices
   
Level 2
Other Significant
Observable Inputs
   
Level 3
Significant
Unobservable Inputs
   
Investments Valued at NAV**
   
Total
 
Common Stock
 
$
123,801,789
   
$
-
   
$
1,454,593
   
$
-
   
$
125,256,382
 
Preferred Stock
   
-
     
-
     
-
     
-
     
-
 
Limited Partnership
   
-
     
-
     
-
     
566,218
     
566,218
 
Short Term Investment
   
364,226
     
-
     
-
     
-
     
364,226
 
Total Investments in Securities
 
$
124,166,015
   
$
-
   
$
1,454,593
   
$
566,218
   
$
126,186,826
 
 
* Please see the Schedule of Investments for industry classifications.
**   As of September 30, 2024, certain of the Fund’s investments were valued using net asset value (“NAV”) per share (or its equivalent) as a practical expedient for fair value and have been excluded from the fair value hierarchy in accordance with ASU 2015-07. The fair value amount presented in this table is intended to permit reconciliation of the amounts presented in the fair value hierarchy to the amounts presented in the schedule of investments.

The Fund values its investment in a private equity limited partnership in accordance with Accounting Standards Codification 820-10-35, “Investments in Certain Entities that Calculate Net Asset Value Per Share (Or its Equivalent)” (“ASC 820-10-35”). ASC 820-10-35 permits a reporting entity to measure the fair value of an investment that does not have a readily determinable fair value, based on the NAV of the investment as a practical expedient, without further adjustment, unless it is probable that the investment will be sold at a value significantly different than the NAV. If the NAV of the investment is not as of the Fund’s measurement date, then the NAV should be adjusted to reflect any significant events that may change the valuation. Inputs and valuation techniques for these adjustments may include fair valuations of the partnership and its portfolio holdings provided by the partnership’s general partner or manager, other available information about the partnership’s portfolio holdings, values obtained on redemption from other limited partners, discussions with the partnership’s general partner or manager and/or other limited partners and comparisons of previously-obtained estimates to the partnership’s audited financial statements. In using the unadjusted NAV as a practical expedient, certain attributes of the investment that may impact its fair value are not considered. Attributes of those investments include the investment strategies of the privately held companies and may also include, but are not limited to, restrictions on the investor’s ability to redeem its investments at the measurement date and any unfunded commitments.

Level 3 securities, which are listed in Note 3 to the Schedule of Investments, consist of the Fund’s investments in privately-held companies.

Inputs and valuation techniques used by the Fund to value its Level 3 investments in privately-held companies may include the following: acquisition cost; fundamental analytical data; discounted cash flow analysis; nature and duration of restrictions on disposition of the investment; public trading of similar securities of similar issuers; economic outlook and condition of the industry in which the issuer participates; financial condition of the issuer; and the issuer’s prospects, including any recent or potential management or capital structure changes. Although these valuation inputs may be observable in the marketplace as is characteristic of Level 2 investments, the privately-held companies, categorized as Level 3 investments, generally are highly illiquid in terms of resale.
 
When valuing Level 3 investments, management also may consider potential events that could have a material impact on the operations of a privately-held company. Not all of these factors may be considered or available, and other relevant factors may be considered on an investment-by-investment basis.

The following is a reconciliation of Level 3 assets for which significant unobservable inputs were used to determine fair value.

LEVEL 3 ROLLFORWARD TABLE

   
Common Stock
   
Preferred Stock
   
Total
 
Balance as of December 31, 2023
 
$
1,341,160
   
$
5,177
   
$
1,346,338
 
Change in Unrealized Appreciation/Depreciation
   
3,120,481
     
1,927,021
     
5,047,501
 
Net Realized Gain (Loss)
   
(3,005,586
)
   
(1,932,198
)
   
(4,937,784
)
Gross Purchases
   
-
     
-
     
-
 
Gross Sales
   
(1,462
)
   
-
     
(1,462
)
Transfer out of Level 3
   
-
     
-
     
-
 
Balance as of September 30, 2024
 
$
1,454,593
   
$
-
   
$
1,454,593
 
Change in unrealized appreciation (depreciation) during the period for Level 3 investments held at September 30, 2024
   
114,923
     
-
     
114,923
 
 
(a)
The noted amounts of change in unrealized appreciation/depreciation relate to the fair value of Level 3 assets held on September 30, 2024.


Swiss Helvetia (NYSE:SWZ)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024 Haga Click aquí para más Gráficas Swiss Helvetia.
Swiss Helvetia (NYSE:SWZ)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024 Haga Click aquí para más Gráficas Swiss Helvetia.